ArticleJournal of clinical medicine2023

Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study.

Giuseppina Miele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.